In Vivo Efficacy Study of Patient Preoperative Preps

Completed · Phase 3

Conditions studied: Bacterial Reduction Post-product Application

In brief

The objective of this study is to demonstrate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Key facts

Study ID

NCT02203591

Run by

3M

People needed

738

Starts

2014-07-01

Expected to finish

2015-03-01

Last updated by the study team

2020-11-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects of any race
• Subjects in good health
• Minimum skin flora baseline requirements on abdomen and groin

You may not qualify if…

• Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test area
• Topical antimicrobial exposure within 14 days prior to screening and treatment days
• Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

Where it is running

• BioScience Laboratories, Inc. — Bozeman, Montana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.